Researchers have uncovered a sequence of biological processes that occur in humans infected with the bacterium Mycobacterium tuberculosis as the infection progresses to pulmonary tuberculosis, according to new research published ...
Nov 16, 2017
0
0
Researchers have shown that a single nucleotide change in a gene that affects production of hepcidin—a peptide involved in inflammation, immunity, and control of iron levels—is associated with greater susceptibility to ...
Jul 21, 2017
0
0
In the time it takes to read this article, half a dozen people will have died from tuberculosis (TB).
Mar 27, 2017
0
1
Researchers at the University of St Andrews are one step closer to finding a shorter, more effective treatment for TB, according to a new paper published by The Lancet Infectious Diseases.
Oct 28, 2016
0
22
"New weapon in fight against the deadliest disease! Medicine can be used to treat existing illness and prevent reoccurrence." These headlines were published 125 years ago and shook up not only the world of science and medicine, ...
Mar 23, 2016
0
8
Researchers from BIOCAPS will collaborate with scientists from seven countries to design a future vaccine against one of the most persistent diseases worldwide, an infectious disease that provokes one death every 24 seconds: ...
May 4, 2015
0
40
The only tuberculosis vaccine currently approved, the Bacillus Calmette-Guérin (BCG) vaccine, protects children from the most severe forms of the disease in most cases but does not provide protection against the most common ...
Mar 24, 2015
0
22
(HealthDay)—In 26 U.S. tuberculosis outbreaks the initial source case-patients had long incubation periods and were characterized by substance abuse, incarceration, and homelessness, according to a study published in the ...
Feb 25, 2015
0
3
One of the roadblocks to the eradication of tuberculosis (TB) is the difficulty in identifying patients with latent TB infections (LTBI). Neither the tuberculin skin test (TST) nor interferon-gamma release assays (IGRAs) ...
Jan 6, 2015
0
9
(HealthDay)—For patients with uncomplicated, smear-positive pulmonary tuberculosis, moxifloxacin-containing regimens over four months are not noninferior to a control regimen, according to a study published online Sept. ...
Sep 8, 2014
0
0
